MétaCan
Menu
← Back to cohort

The effect of doxycycline on bone turnover and tumor markers in breast cancer (BC) patients with skeletal metastases

2005· article· en· W2202891164 on OpenAlexaff
Sukhbinder Dhesy‐Thind, JoAnne Julian, Richard Tozer, Peter Ellis, Andrew Arnold, Gurmit Singh, Mark N. Levine

Bibliographic record

VenueJournal of Clinical Oncology · 2005
Typearticle
Languageen
FieldMedicine
TopicBone health and treatments
Canadian institutionsJuravinski Cancer Centre
Fundersnot available
KeywordsMedicineBone remodelingBisphosphonateInternal medicineN-terminal telopeptideChemotherapyBone resorptionCancerBreast cancerOsteosarcomaDoxycyclineAlkaline phosphataseOncologyGastroenterologyPathologyOsteocalcinOsteoporosisAntibiotics

Abstract

fetched live from OpenAlex

3198 Background: Doxycycline is a tetracycline analogue which is osteotropic with high affinity for mineralized bone. In experimental systems, it has anti-cancer effects including inhibition of matrix metallo proteinases, anti-angiogenic activity and a cytostatic effect on cancer cells. Methods: 17 patients with newly diagnosed bone metastases from BC, and no prior bisphosphonate therapy were treated with Doxycycline 100 mg po bid for 3 months. Treatment was discontinued for disease progression or unacceptable toxicity. Bone scans and serum bone markers [N-telopeptide (NTx - Osteomark NTx Serum) and bone specific alkaline phosphatase (BAP - Metra BAP)] were measured as markers of bone turnover and PTHrP as a marker of tumor progression at baseline and following 12 weeks of therapy. Patients subsequently received bisphosphonate therapy. The primary outcome was a 50% relative decrease in serum bone markers. Results: 12 patients were evaluable for response, 3 patients discontinued therapy due to toxicity and were non-evaluable, and results are pending for 2 others. Median age was 62.5 years and 4 patients had other metastatic sites. 3 patients received concurrent chemotherapy and 9 patients hormonal treatment. There were no cases of pathological fractures or hypercalcemia. Results of the bone markers studies are shown below. 11 of 12 patients had normal serum NTx values and 5/12 had normal BAP at baseline despite extensive bone metastases. PTHrP levels in 9 of 12 patients either declined or remained at the same level after 12 weeks. Conclusions: Although Doxycycline for 3 months was associated with a drop in serum bone markers in some patients, it failed to satisfy the pre-specified outcome measure of a 50% decrease. A possible explanation is the lack of responsiveness of the outcome measure. Our study demonstrated the feasibility of administration of long-term Doxycycline. Further studies evaluating this agent are warranted. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.410
Teacher spread0.387 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicBone health and treatments→French-language works237,207→